1:14 PM
 | 
Aug 16, 2017
 |  BC Extra  |  Financial News

FibroGen raises $326 million in follow-on

FibroGen Inc. (NASDAQ:FGEN) raised $326 million through the sale of 8 million shares at $40.75 in a follow-on underwritten by Goldman Sachs, Citigroup and Leerink. The price is a 7% discount to FibroGen's closing price...

Read the full 157 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >